![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1571, 2007-01, pp. : 11-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
NHL gets the CHOP with rituximab
Inpharma, Vol. 1, Iss. 1226, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Rituximab + CHOP induces long-term response in NHL
Inpharma, Vol. 1, Iss. 1466, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Rituximab plus CHOP advances in aggressive NHL
Inpharma, Vol. 1, Iss. 1322, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Rituximab plus CHOP induction beneficial in aggressive NHL
Inpharma, Vol. 1, Iss. 1425, 2004-01 ,pp. :